180 related articles for article (PubMed ID: 26319201)
1. Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.
Wang X; Harrison JS; Studzinski GP
J Steroid Biochem Mol Biol; 2016 Nov; 164():72-78. PubMed ID: 26319201
[TBL] [Abstract][Full Text] [Related]
2. The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts.
Harrison JS; Wang X; Studzinski GP
Oncotarget; 2016 Jun; 7(24):36447-36460. PubMed ID: 27144333
[TBL] [Abstract][Full Text] [Related]
3. Differentiation agents increase the potential AraC therapy of AML by reactivating cell death pathways without enhancing ROS generation.
Wang X; Dawod A; Nachliely M; Harrison JS; Danilenko M; Studzinski GP
J Cell Physiol; 2020 Jan; 235(1):573-586. PubMed ID: 31245853
[TBL] [Abstract][Full Text] [Related]
4. Optimal AraC-Cytotoxicity to AML Cells Requires ERK5 Activity.
Zheng R; Studzinski GP
J Cell Biochem; 2017 Jun; 118(6):1583-1589. PubMed ID: 27922189
[TBL] [Abstract][Full Text] [Related]
5. Involvement of microRNA181a in differentiation and cell cycle arrest induced by a plant-derived antioxidant carnosic acid and vitamin D analog doxercalciferol in human leukemia cells.
Duggal J; Harrison JS; Studzinski GP; Wang X
Microrna; 2012; 1(1):26-33. PubMed ID: 25048087
[TBL] [Abstract][Full Text] [Related]
6. Participation of vitamin D-upregulated protein 1 (TXNIP)-ASK1-JNK1 signalosome in the enhancement of AML cell death by a post-cytotoxic differentiation regimen.
Wang X; Nachliely M; Harrison JS; Danilenko M; Studzinski GP
J Steroid Biochem Mol Biol; 2019 Mar; 187():166-173. PubMed ID: 30508644
[TBL] [Abstract][Full Text] [Related]
7. Novel analogs of 1,25-dihydroxyvitamin D
Nachliely M; Sharony E; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2016 Nov; 164():59-65. PubMed ID: 26365556
[TBL] [Abstract][Full Text] [Related]
8. Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.
Pigneux A; Mahon FX; Uhalde M; Jeanneteau M; Lacombe F; Milpied N; Reiffers J; Belloc F
Exp Hematol; 2008 Dec; 36(12):1648-59. PubMed ID: 18922616
[TBL] [Abstract][Full Text] [Related]
9. Prodifferentiation Activity of Novel Vitamin D₂ Analogs PRI-1916 and PRI-1917 and Their Combinations with a Plant Polyphenol in Acute Myeloid Leukemia Cells.
Nachliely M; Sharony E; Bolla NR; Kutner A; Danilenko M
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399677
[TBL] [Abstract][Full Text] [Related]
10. BRAF signals to pro-apoptotic BIM to enhance AraC cytotoxicity induced in AML cells by Vitamin D-based differentiation agents.
Wang X; Harrison JS; Studzinski GP
J Steroid Biochem Mol Biol; 2017 Oct; 173():139-147. PubMed ID: 27637326
[TBL] [Abstract][Full Text] [Related]
11. Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.
Chromik J; Safferthal C; Serve H; Fulda S
Cancer Lett; 2014 Mar; 344(1):101-109. PubMed ID: 24184825
[TBL] [Abstract][Full Text] [Related]
12. JNK1 as a signaling node in VDR-BRAF induction of cell death in AML.
Wang X; Beute WK; Harrison JS; Studzinski GP
J Steroid Biochem Mol Biol; 2018 Mar; 177():149-154. PubMed ID: 28765039
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis.
Liu N; Wang C; Wang L; Gao L; Cheng H; Tang G; Hu X; Wang J
Int J Mol Med; 2016 Jun; 37(6):1686-96. PubMed ID: 27082972
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to Cytarabine.
Visser N; Lourens HJ; Huls G; Bremer E; Wiersma VR
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652766
[TBL] [Abstract][Full Text] [Related]
15. Enhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance.
Cheong JW; Kim Y; Eom JI; Jeung HK; Min YH
Mol Med Rep; 2016 Apr; 13(4):3433-40. PubMed ID: 26935591
[TBL] [Abstract][Full Text] [Related]
16. Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia.
Caldwell JT; Edwards H; Buck SA; Ge Y; Taub JW
Pediatr Blood Cancer; 2014 Oct; 61(10):1767-73. PubMed ID: 24962331
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of MEK signaling enhances the ability of cytarabine to induce growth arrest and apoptosis of acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Yokoyama A
Apoptosis; 2009 Sep; 14(9):1108-20. PubMed ID: 19548087
[TBL] [Abstract][Full Text] [Related]
18. Obatoclax potentiates the cytotoxic effect of cytarabine on acute myeloid leukemia cells by enhancing DNA damage.
Xie C; Edwards H; Caldwell JT; Wang G; Taub JW; Ge Y
Mol Oncol; 2015 Feb; 9(2):409-21. PubMed ID: 25308513
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells.
Ma J; Li X; Su Y; Zhao J; Luedtke DA; Epshteyn V; Edwards H; Wang G; Wang Z; Chu R; Taub JW; Lin H; Wang Y; Ge Y
Sci Rep; 2017 Feb; 7():41950. PubMed ID: 28176818
[TBL] [Abstract][Full Text] [Related]
20. Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.
Österroos A; Kashif M; Haglund C; Blom K; Höglund M; Andersson C; Gustafsson MG; Eriksson A; Larsson R
Biochem Pharmacol; 2016 Oct; 118():40-49. PubMed ID: 27565890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
